The global Water for Injection (WFI) market size is predicted to grow from US$ 25630 million in 2025 to US$ 37250 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.

Water for Injection (WFI) refers to a highly purified water used in the production of pharmaceuticals and medical devices. It is prepared according to rigorous quality standards and must meet the requirements specified by pharmacopoeial authorities. WFI should be free from impurities, such as microorganisms, endotoxins, and particles, and be suitable for parenteral administration (administered through injection). WFI is typically used in the formulation, manufacturing, and testing of pharmaceutical products, as well as for the cleaning and sterilization of equipment and packaging materials.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents? wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

LP Information, Inc. (LPI) ' newest research report, the ?Water for Injection (WFI) Industry Forecast? looks at past sales and reviews total world Water for Injection (WFI) sales in 2024, providing a comprehensive analysis by region and market sector of projected Water for Injection (WFI) sales for 2025 through 2031. With Water for Injection (WFI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Water for Injection (WFI) industry.

This Insight Report provides a comprehensive analysis of the global Water for Injection (WFI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Water for Injection (WFI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Water for Injection (WFI) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Water for Injection (WFI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Water for Injection (WFI).

This report presents a comprehensive overview, market shares, and growth opportunities of Water for Injection (WFI) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Bacteriostatic Water for Injection
    Sterile Water for Injection

Segmentation by Application:

    Research Institutes
    Hospitals
    Clinics
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Abbott Laboratories
    Johnson and Johnson
    Acella Pharmaceuticals
    Merck KGaA
    AdvaCare Pharma
    B. Braun SE
    FUJIFILM Holdings
    GlaxoSmithKline
    Merit Healthcare International
    Novartis AG
    Pfizer
    Pharma Cure Laboratories
    Sanofi
    Zhejiang Tianrui Pharmaceutical
    Zhuhai Tongyuan Pharmaceutical
    Shandong Kanghua

Key Questions Addressed in this Report

What is the 10-year outlook for the global Water for Injection (WFI) market?
What factors are driving Water for Injection (WFI) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Water for Injection (WFI) market opportunities vary by end market size?
How does Water for Injection (WFI) break out by Type, by Application?